Brand Name
Lescol
Generic Name
Fluvastatin
View Brand Information FDA approval date: October 06, 2000
Classification: HMG-CoA Reductase Inhibitor
Form: Tablet, Capsule
What is Lescol (Fluvastatin)?
LESCOL XL is indicated: To reduce the risk of undergoing coronary revascularization procedures and slow the progression of coronary atherosclerosis in adults with clinically evident coronary heart disease., As an adjunct to diet to reduce low-density lipoprotein cholesterol in adults with primary hyperlipidemia., As an adjunct to diet to reduce LDL-C in adults and pediatric patients 10 years of age and older with heterozygous familial hypercholesterolemia who require 80 mg of fluvastatin daily. LESCOL XL is indicated :, To reduce the risk of undergoing coronary revascularization procedures and slow the progression of coronary atherosclerosis in adults with clinically evident coronary heart disease., As an adjunct to diet to reduce low-density lipoprotein cholesterol in adults with primary hyperlipidemia., As an adjunct to diet to reduce LDL-C in adults and pediatric patients 10 years of age and older with heterozygous familial hypercholesterolemia who require 80 mg.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment


